Literature DB >> 23449291

Nanomedicine: is the wave cresting?

Rudy Juliano1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23449291      PMCID： PMC3689268          DOI： 10.1038/nrd3958

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

Review 1.  Nanomedicine(s) under the microscope.

Authors:  Ruth Duncan; Rogerio Gaspar
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

Review 2.  How much is the life of a cancer patient worth? A pharmaco-economic perspective.

Authors:  S Simoens; M Dooms
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

Review 3.  Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.

Authors:  Zhiliang Cheng; Ajlan Al Zaki; James Z Hui; Vladimir R Muzykantov; Andrew Tsourkas
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

Review 4.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

Authors:  Vikash P Chauhan; Triantafyllos Stylianopoulos; Yves Boucher; Rakesh K Jain
Journal:  Annu Rev Chem Biomol Eng       Date:  2011       Impact factor: 11.059

Review 5.  Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry.

Authors:  Hiroaki Yokomori; Masaya Oda; Kazunori Yoshimura; Toshifumu Hibi
Journal:  Micron       Date:  2011-08-11       Impact factor: 2.251

Review 6.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

Review 7.  Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin.

Authors:  Rebecca Soloman; Alberto A Gabizon
Journal:  Clin Lymphoma Myeloma       Date:  2008-02
  7 in total
  20 in total

1.  Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Authors:  Jiang-Jiang Qin; Wei Wang; Sushanta Sarkar; Ruiwen Zhang
Journal:  J Control Release       Date:  2016-07-06       Impact factor: 9.776

2.  Charge-transfer interactions induce surface dependent conformational changes in apolipoprotein biocorona.

Authors:  Achyut J Raghavendra; Nasser Alsaleh; Jared M Brown; Ramakrishna Podila
Journal:  Biointerphases       Date:  2017-03-07       Impact factor: 2.456

3.  Imaging-guided revival of nanomedicine?

Authors:  Max L Senders; Zahi A Fayad; Thomas Reiner; Willem Jm Mulder; Carlos Pérez-Medina
Journal:  Nanomedicine (Lond)       Date:  2016-11-23       Impact factor: 5.307

Review 4.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

Review 5.  Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.

Authors:  Henry A Havel
Journal:  AAPS J       Date:  2016-08-12       Impact factor: 4.009

Review 6.  Revisiting the cytotoxicity of quantum dots: an in-depth overview.

Authors:  Sohrab Nikazar; Vishnu Sankar Sivasankarapillai; Abbas Rahdar; Salim Gasmi; P S Anumol; Muhammad Salman Shanavas
Journal:  Biophys Rev       Date:  2020-03-05

7.  A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines.

Authors:  Jun Tang; Carlos Pérez-Medina; Yiming Zhao; Ahmad Sadique; Willem J M Mulder; Thomas Reiner
Journal:  J Vis Exp       Date:  2017-03-04       Impact factor: 1.355

8.  Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.

Authors:  Jinxie Zhang; Wei Tao; Yuhan Chen; Danfeng Chang; Teng Wang; Xudong Zhang; Lin Mei; Xiaowei Zeng; Laiqiang Huang
Journal:  J Mater Sci Mater Med       Date:  2015-03-20       Impact factor: 3.896

9.  Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites.

Authors:  Qilong Wang; Yi Ren; Jingyao Mu; Nejat K Egilmez; Xiaoyin Zhuang; Zhongbin Deng; Lifeng Zhang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Res       Date:  2015-04-16       Impact factor: 12.701

10.  Design principles for clinical efficacy of cancer nanomedicine: a look into the basics.

Authors:  Shiladitya Sengupta; Ashish Kulkarni
Journal:  ACS Nano       Date:  2013-04-23       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.